ClinicalTrials.Veeva

Menu

Ionized Magnesium Balance During Hemodialysis Session (MAGNESIR)

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Unknown

Conditions

Chronic Kidney Diseases

Treatments

Biological: Total and ionized magnesium
Biological: Total and ionized calcium
Biological: Lymphatic drainage

Study type

Observational

Funder types

Other

Identifiers

NCT05337436
RECHMPL22_0004

Details and patient eligibility

About

Aim of this study is to evaluate in a population of chronic kidney disease patients on dialysis (Stage 5D) the balance of total and ionized magnesium according to different types of dialysate used in clinical practice (acetate + Mg 0.50 or 0.75 mM vs citrate + Mg 0.50 ou 0.75 mM)

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Chronic Kidney Disease patient on dialysis (stage 5D) for more than 1 month
  • Anuric patient

Exclusion criteria

  • Patient protected by law
  • Patient under guardianship ou curatorship
  • Patient deprived of liberty

Trial design

150 participants in 1 patient group

All patients receive conventional dialysis treatment at enrollment
Description:
All patients receive conventional dialysis treatment at enrollment
Treatment:
Biological: Lymphatic drainage
Biological: Total and ionized magnesium
Biological: Total and ionized calcium

Trial contacts and locations

1

Loading...

Central trial contact

Jean-Paul CRISTOL, Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems